Tsfg, LLC Charles River Laboratories International, Inc. Transaction History

Tsfg, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$206.39 - $268.73 $29,307 - $38,159	-142 Reduced 94.67%	8 $2,000
Q4 2023 Jan 23, 2024	SELL	$164.52 - $238.84 $1,316 - $1,910	-8 Reduced 5.06%	150 $35,000
Q2 2023 Jul 10, 2023	BUY	$183.71 - $210.25 $9,552 - $10,933	52 Added 49.06%	158 $33,000
Q3 2022 Oct 20, 2022	SELL	$182.44 - $250.54 $31,379 - $43,092	-172 Reduced 61.87%	106 $21,000
Q1 2022 Apr 25, 2022	SELL	$255.51 - $362.11 $2,555 - $3,621	-10 Reduced 3.47%	278 $79,000
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $15,812 - $20,190	45 Added 18.52%	288 $109,000
Q4 2020 Jan 20, 2021	BUY	$222.0 - $252.62 $53,946 - $61,386	243 New	243 $61,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.